Literature DB >> 31737191

Tumor-associated macrophages increase the proportion of cancer stem cells in lymphoma by secreting pleiotrophin.

Xia Wei1, Sainan Yang1, Xin Pu1, Silian He1, Zailin Yang1, Xiaomin Sheng1, Xiaoqin Meng1, Xue Chen1, Ling Jin1, Wen Chen2, Yong Zhang1.   

Abstract

Tumor-associated macrophages (TAMs) are closely related to the occurrence and development of lymphoma, but their mechanism is still unclear. Here we collected peripheral blood and lymphoma tissue from patients with diffuse large B lymphoma. Results showed that the proportion of TAMs in high-risk group was significantly higher than that in low-risk group. Moreover, the expressions of pleiotrophin (PTN), PTPRZ1 (PTN receptor) and β-catenin in lymphoma tissues of high-risk group were also significantly higher than those in low-risk group. Correlation analysis showed that the proportion of TAMs in lymphocyte was positively correlated with the expression of PTN and PTPRZ1 in lymphoma tissue. In vitro experimental results showed that TAM promoted the invasion and proliferation of lymphoma cells by secreting PTN. We also found that TAMs increased the proportion of cancer stem cells in lymphoma. Animal experiments showed that TAMs promoted lymphoma growth. Both Ki-67 proliferation index and CD44+cancer stem cells increased significantly in TAM group. Blocking PTN or β-catenin partly inhibited these effects of TAMs. In conclusion, TAMs increased the proportion of cancer stem cells through PTN/β-catenin pathway in lymphoma. AJTR
Copyright © 2019.

Entities:  

Keywords:  Lymphoma; cancer stem cell; pleiotrophin; tumor-associated macrophage

Year:  2019        PMID: 31737191      PMCID: PMC6834503     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  23 in total

1.  A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential.

Authors:  Chung-Gi Lee; Bikul Das; Tara L Lin; Chelsea Grimes; Xin Zhang; Tracey Lavezzi; Li Huang; John Cole; Lillian Yau; Li Li
Journal:  Br J Haematol       Date:  2012-04-18       Impact factor: 6.998

2.  Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.

Authors:  Lisanne S Rigter; Petur Snaebjornsson; Efraim H Rosenberg; Peggy N Atmodimedjo; Berthe M Aleman; Jelle Ten Hoeve; Willemina R Geurts-Giele; Thomas W van Ravesteyn; Johan Hoeksel; Gerrit A Meijer; Hein Te Riele; Flora E van Leeuwen; Winand N Dinjens; Monique E van Leerdam
Journal:  Gut       Date:  2016-11-08       Impact factor: 23.059

3.  Immunohistochemical and quantitative competitive PCR analyses of midkine and pleiotrophin expression in cervical cancer.

Authors:  Hye-Sung Moon; Won I Park; Sun Hee Sung; Eun-Ah Choi; Hye-Won Chung; Bock Hi Woo
Journal:  Gynecol Oncol       Date:  2003-03       Impact factor: 5.482

Review 4.  Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis.

Authors:  Takashi Muramatsu
Journal:  J Biochem       Date:  2002-09       Impact factor: 3.387

5.  Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer.

Authors:  W Fang; N Hartmann; D T Chow; A T Riegel; A Wellstein
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

6.  N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells.

Authors:  Min Wang; Dong Ren; Wei Guo; Shuai Huang; Zeyu Wang; Qiji Li; Hong Du; Libing Song; Xinsheng Peng
Journal:  Int J Oncol       Date:  2015-11-26       Impact factor: 5.650

7.  A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.

Authors:  Minna Taskinen; Marja-Liisa Karjalainen-Lindsberg; Heidi Nyman; Leena-Maija Eerola; Sirpa Leppä
Journal:  Clin Cancer Res       Date:  2007-10-01       Impact factor: 12.531

8.  Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.

Authors:  Qiang Fu; Le Xu; Yiwei Wang; Qi Jiang; Zheng Liu; Junyu Zhang; Quan Zhou; Han Zeng; Shanyou Tong; Tao Wang; Yangyang Qi; Baoying Hu; Hangcheng Fu; Huyang Xie; Lin Zhou; Yuan Chang; Yu Zhu; Bo Dai; Weijuan Zhang; Jiejie Xu
Journal:  Eur Urol       Date:  2018-10-04       Impact factor: 20.096

9.  Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer.

Authors:  Youn Hee Jee; Samira M Sadowski; Francesco S Celi; Liqiang Xi; Mark Raffeld; David B Sacks; Alan T Remaley; Anton Wellstein; Electron Kebebew; Jeffrey Baron
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

10.  Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth.

Authors:  Yu Shi; Yi-Fang Ping; Wenchao Zhou; Zhi-Cheng He; Cong Chen; Bai-Shi-Jiao Bian; Lin Zhang; Lu Chen; Xun Lan; Xian-Chao Zhang; Kai Zhou; Qing Liu; Hua Long; Ti-Wei Fu; Xiao-Ning Zhang; Mian-Fu Cao; Zhi Huang; Xiaoguang Fang; Xiuxing Wang; Hua Feng; Xiao-Hong Yao; Shi-Cang Yu; You-Hong Cui; Xia Zhang; Jeremy N Rich; Shideng Bao; Xiu-Wu Bian
Journal:  Nat Commun       Date:  2017-06-01       Impact factor: 14.919

View more
  12 in total

1.  Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.

Authors:  Arnon Møldrup Knudsen; Bo Halle; Oriane Cédile; Mark Burton; Christina Baun; Helge Thisgaard; Atul Anand; Christopher Hubert; Mads Thomassen; Signe Regner Michaelsen; Birgitte Brinkmann Olsen; Rikke Hedegaard Dahlrot; Rolf Bjerkvig; Justin Durla Lathia; Bjarne Winther Kristensen
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

Review 2.  The resistance mechanisms and treatment strategies of BTK inhibitors in B-cell lymphoma.

Authors:  Haoran Wang; Wentao Zhang; Jingyi Yang; Keshu Zhou
Journal:  Hematol Oncol       Date:  2021-10-15       Impact factor: 4.850

Review 3.  Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell lymphomas.

Authors:  Bhawana George; Sayan Mullick Chowdhury; Amber Hart; Anuvrat Sircar; Satish Kumar Singh; Uttam Kumar Nath; Mukesh Mamgain; Naveen Kumar Singhal; Lalit Sehgal; Neeraj Jain
Journal:  Cancers (Basel)       Date:  2020-05-22       Impact factor: 6.639

4.  Apurinic/apyrimidinic endonuclease 1/reduction-oxidation effector factor-1 (APE1) regulates the expression of NLR family pyrin domain containing 3 (NLRP3) inflammasome through modulating transcription factor NF-κB and promoting the secretion of inflammatory mediators in macrophages.

Authors:  Zheng Tang; Ying Wang; Yue Wan; Yue Xie; Shujie Li; Dan Tao; Can Wang; Yong-Zhong Wu; Jiang-Dong Sui
Journal:  Ann Transl Med       Date:  2021-01

Review 5.  Molecular pathology underlying the robustness of cancer stem cells.

Authors:  Go J Yoshida; Hideyuki Saya
Journal:  Regen Ther       Date:  2021-03-25       Impact factor: 3.419

6.  Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.

Authors:  He Huang; Shilei Xu; Aidong Chen; Fen Li; Jiezhong Wu; Xusheng Tu; Kunpeng Hu
Journal:  Anal Cell Pathol (Amst)       Date:  2021-03-23       Impact factor: 2.916

Review 7.  Cancer Stemness Meets Immunity: From Mechanism to Therapy.

Authors:  Peiwen Chen; Wen-Hao Hsu; Jincheng Han; Yan Xia; Ronald A DePinho
Journal:  Cell Rep       Date:  2021-01-05       Impact factor: 9.423

8.  Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence.

Authors:  Haoxin Peng; Xiangrong Wu; Ran Zhong; Tao Yu; Xiuyu Cai; Jun Liu; Yaokai Wen; Yiyuan Ao; Jiana Chen; Yutian Li; Miao He; Caichen Li; Hongbo Zheng; Yanhui Chen; Zhenkui Pan; Jianxing He; Wenhua Liang
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

9.  Based on Molecular Subtypes, Immune Characteristics and Genomic Variation to Constructing and Verifying Multi-Gene Prognostic Characteristics of Colorectal Cancer.

Authors:  Lei Gu; Chunhui Jiang; Chunjie Xu; Ye Liu; Hong Zhou
Journal:  Front Cell Dev Biol       Date:  2022-02-23

Review 10.  Macrophages and cancer stem cells: a malevolent alliance.

Authors:  Paola Allavena; Elisabeth Digifico; Cristina Belgiovine
Journal:  Mol Med       Date:  2021-09-28       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.